Accuracy and Clinical Utility of a Point-of-Care HbA1c, Testing Device
- 1 May 2013
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 125 (3) , 91-98
Abstract
Background: Point-of-care testing (POCT) is widely used to measure blood glucose levels in people with diabetes, although its use in measuring glycated hemoglobin (HbA(1c)) levels is less common, perhaps due to perceived performance issues and access to the technology. Methods: Forty blood samples were analyzed in duplicate using Bayer's A1CNow(+)(R) Multi-Test A1C system (A1CNow(+)) with 3 different reagent lots; HbA(1c) levels of the samples spanned the clinically relevant range of 4% to 10%. Corresponding samples were sent to a National Glycohemoglobin Standardization Program (NGSP) secondary reference laboratory (University of Missouri Secondary Reference Laboratory #9), which analyzed the samples with a Tosoh Automated Glycohemoglobin Analyzer HLC-723G8 (Tosoh G8; Tosoh Bioscience, Inc). Results: Glycated hemoglobin levels measured with the A1CNow(+) aligned with measurements obtained using the laboratory method, with correlation coefficients of 0.985, 0.987, and 0.989 for the 3 lots, respectively. The 95% CIs for the differences between the A1CNow(+) levels and the mean HbA(1c) levels were within -0.55% to +0.50% for the 3 reagent lots, which is well within the currently acceptable limits of +/- 0.75% HbA(1c) required by the NGSP. Results were further analyzed per the new tighter NGSP performance criteria effective September 1, 2012, requiring that 37 of 40 results be within +/- 7% (relative bias) of the NGSP reference laboratory measures. All 3 lots met the tighter NGSP criteria. Conclusion: The A1CNow(+) provides accuracy and precision when performing POCT of HbA(1c) as an aid in diabetes management. Ongoing improvements in this and other HbA(1c) POCT devices may lead to a greater global acceptance of the role of POCT of HbA(1c) in diabetes management.Keywords
This publication has 18 references indexed in Scilit:
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care PlanEndocrine Practice, 2011
- Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysisPediatrics, 2009
- Relationship Between Patient Medication Adherence and Subsequent Clinical Inertia in Type 2 Diabetes Glycemic ManagementDiabetes Care, 2007
- Effect of Immediate Hemoglobin A1c Results on Treatment Decisions in Office PracticeEndocrine Practice, 2001
- Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)BMJ, 2001
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.Diabetes Care, 1999
- Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993